VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $49,100,000 | -2.5% | 2,000,000 | -20.0% | 5.34% | -4.7% |
| Q2 2016 | $50,350,000 | +1.4% | 2,500,000 | +900.0% | 5.61% | +49.3% |
| Q1 2015 | $49,655,000 | -30.6% | 250,000 | -50.0% | 3.76% | -21.9% |
| Q4 2014 | $71,555,000 | +9.1% | 500,000 | 0.0% | 4.81% | -3.8% |
| Q3 2014 | $65,600,000 | +4.0% | 500,000 | 0.0% | 5.00% | +13.3% |
| Q2 2014 | $63,060,000 | – | 500,000 | – | 4.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |